Showing results (41-50 of 58) with videos related to
Sort By:
Pageof 6
Neuroscience|November 24, 2005
Transgenic mice over-expressing human beta-amyloid have functional nicotinic alpha 7 receptorsJ P Spencer, A Weil, K Hill, et al.Neuroscience|April 13, 2001
Distribution and expression of TREK-1, a two-pore-domain potassium channel, in the adult rat CNSG J Hervieu, J E Cluderay, C W Gray, et al.Neuroscience|October 19, 2004
Modulation of hippocampal excitability by 5-HT4 receptor agonists persists in a transgenic model of Alzheimer's diseaseJ P Spencer, J T Brown, J C Richardson, et al.The Journal of Physiology|June 5, 2001
Kinetic modification of the alpha(1I) subunit-mediated T-type Ca(2+) channel by a human neuronal Ca(2+) channel gamma subunitP J Green, R Warre, P D Hayes, et al.Brain Research|February 15, 2001
The neuroprotective agent sipatrigine (BW619C89) potently inhibits the human tandem pore-domain K(+) channels TREK-1 and TRAAKH J Meadows, C G Chapman, D M Duckworth, et al.Neuropharmacology|November 1, 1993
Distinctive pharmacology and kinetics of cloned neuronal Ca2+ channels and their possible counterparts in mammalian CNS neuronsJ F Zhang, A D Randall, P T Ellinor, et al.British Journal of Pharmacology|February 29, 2000
The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1)D Smart, M J Gunthorpe, J C Jerman, et al.European Journal of Pharmacology|April 13, 2001
Characterisation using FLIPR of human vanilloid VR1 receptor pharmacologyD Smart, J C Jerman, M J Gunthorpe, et al.Brain Research|November 10, 2001
Neuroprotective actions in vivo and electrophysiological actions in vitro of 202W92L Caputi, A H Hainsworth, F Lavaroni, et al.Brain Research. Molecular Brain Research|October 24, 2000
Cloning, localisation and functional expression of a novel human, cerebellum specific, two pore domain potassium channelC G Chapman, H J Meadows, R J Godden, et al.Pageof 6